Disparate effects of prazosin and propranolol on lipid metabolism in a rat model.
The effects of 14 days of daily intraperitoneal injections of prazosin hydrochloride (3.0 or 0.3 mg/kg) or propranolol (5 mg/kg) on various aspects of the lipid metabolism of normal rats was studied. The results indicate that plasma triglyceride and cholesterol concentrations were lower and the ratio of plasma HDL-cholesterol to total cholesterol concentration higher in prazosin-treated rats compared with propranolol-treated rats. The decline in plasma triglyceride levels in prazosin-treated rats was associated with a commensurate reduction in triglyceride secretion rates. Plasma free fatty acid levels were also lower in prazosin-treated rats, and this change may have contributed to the fall in triglyceride secretion rates. These data demonstrate that the disparate effects of alpha and beta receptor antagonists, previously shown to occur in hypertensive humans, can be duplicated in normal rats.
D000818:Animals; D002784:Cholesterol / Q000097:blood; D004195:Disease Models, Animal; D006973:Hypertension / Q000378:metabolism*; D050356:Lipid Metabolism; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D011224:Prazosin / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D014280:Triglycerides / Q000097:blood
D008079:Lipoproteins, VLDL; D011799:Quinazolines; D014280:Triglycerides; C030106:very low density lipoprotein triglyceride; D002784:Cholesterol; D011433:Propranolol; D011224:Prazosin